ACP Suggests First-Line Obesity Drugs - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

ACP Suggests First-Line Obesity Drugs

Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.

  • By

  • Kathryn Wighton

  • June 16, 2026

  • 5 min

Share

Original Source(s)

ACP Suggests First-Line Obesity Drugs

  • by Kathryn Wighton

  • June 16, 2026

Related Content

Case Report: ACTH-independent Cushing’s syndrome caused by isolated micronodular adrenal disease in a 23-month-old girl

Behavior Change Content and Implementation of Large Language Model–Driven Conversational Agents in Cardiometabolic Care: Scoping Review

Postoperative Changes in Eating Behavior After Sleeve Gastrectomy are Associated With IL-10 Independent of Anthropometric Changes